---
schema_version: "secwatch.filing_event.v1"
accession: "0001356576-25-000011"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2025-02-24T23:59:59+00:00"
generated_at: "2026-05-26T05:34:45.770691+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Supernus approves executive salary increases and equity awards for 2025

## Summary
- CEO Jack Khattar base salary raised to $1,036,000; 2024 bonus $826,254; awarded 331,660 options and 198,996 PSUs.
- CFO Timothy Dec base salary raised to $504,900; 2024 bonus $229,160; awarded 40,000 options, 4,500 RSUs, 5,000 PSUs.
- Three other execs (Bhatt, Rubin, Mottola) got salary increases, 2024 bonuses, and similar equity grants.
- All 2025 bonus targets unchanged from 2024; salary increases effective Jan 1, 2025.

## SEC filing metadata
- accession: 0001356576-25-000011
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2025-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000011/0001356576-25-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000011/supn-20250224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001356576-25-000011
- JSON: https://secwatch.observer/filing/0001356576-25-000011.json
- Plain text: https://secwatch.observer/filing/0001356576-25-000011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.